NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-171-2018-9-US-04 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/513,933 Pending
NHGRI E-164-2020-2-PCT-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS PCT PCT COMB PCT/US2019/042073 Expired
NHGRI E-164-2020-2-CN-03 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS CN National Stage 201980057936.9 Pending
NHGRI E-044-2013-1-HK-17 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA HK EP 19126894.5 Pending
NHGRI E-164-2020-2-EP-09 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS EP National Stage 19749899.1 Pending
NHGRI E-164-2020-2-JP-11 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS JP National Stage 2021-526207 Pending
NHGRI E-164-2020-2-MX-07 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS MX National Stage MX/A/2021/000638 Pending
NHGRI E-164-2020-2-AU-02 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS AU National Stage 2019304992 Pending
NHGRI E-164-2020-2-BR-06 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS BR National Stage BR112021000675-3 Pending
NHGRI E-164-2020-2-IL-04 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS IL National Stage 2047-01-28 Pending
NHGRI E-164-2020-2-IN-10 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS IN National Stage 202117002972 Pending
NHGRI E-164-2020-2-CA-08 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS CA National Stage 3106640 Pending
NHGRI E-164-2020-2-KR-05 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS KR National Stage 10-2021-7004181 Pending
NHGRI E-164-2020-3-US-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS US CIP 16/513,576 Pending
NEI E-094-2016-0-US-03 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY US National Stage 16/478,093 11819020 Issued PDF
Leidos E-011-2019-1-PCT-01 Cell Linkers for Heterotypic Cell Spheroids PCT PCT PCT/US2019/041800 Expired
NCI E-053-2015-1-EP-05 MYC G-Quadruplex Stabilizing Small Molecules and Their Use EP DIV 19185807.5 Issued
NCI E-053-2015-1-FR-14 MYC G-Quadruplex Stabilizing Small Molecules and Their Use FR EP 19185807.5 Issued
NCI E-053-2015-1-DE-13 MYC G-Quadruplex Stabilizing Small Molecules and Their Use DE EP 19185807.5 Issued
NCI E-053-2015-1-GB-15 MYC G-Quadruplex Stabilizing Small Molecules and Their Use GB EP 19185807.5 Issued
NCI E-053-2015-1-CH-12 MYC G-Quadruplex Stabilizing Small Molecules and Their Use CH EP 19185807.5 Issued
NCI E-154-2018-0-PCT-02 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2019/041464 Expired
NCI E-161-2018-0-PCT-02 Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development PCT PCT PCT/US2019/041401 Expired
NCI E-161-2018-0-EP-05 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF EP National Stage 19746264.1 Pending
NCI E-154-2018-0-EP-04 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME EP National Stage 19746275.7 Pending
NCI E-161-2018-0-JP-06 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF JP National Stage 2021-500651 Pending
NCI E-154-2018-0-JP-05 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME JP National Stage 2021-500734 Issued
NCI E-161-2018-0-AU-03 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF AU National Stage 2019301675 Pending
NCI E-154-2018-0-CA-03 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME CA National Stage 3106008 Pending
NCI E-161-2018-0-CA-04 Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development CA National Stage 3105694 Pending
NLM E-111-2016-7-HK-07 Novel CRISPR Enzymes And Systems HK National Stage 19126548.7 Pending
NLM E-110-2016-2-HK-07 Novel CRISPR Enzymes And Systems HK National Stage 19126549.5 Pending
NIBIB E-005-2012-3-US-11 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US National Stage 16/475,508 11086113 Issued PDF
NIAID E-004-2009-2-EP-18 Viral Like Particle Compositions and Methods of Use EP DIV 19183770.7 Pending
NCI E-247-2015-0-US-07 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA US DIV 16/459,396 11111306 Issued PDF
NCI E-184-2009-0-US-21 Combination Immunotherapy Compositions And Methods US CON 16/458,726 10874729 Issued PDF
NCI E-213-2018-0-NZ-10 TRITERPENE AMINE DERIVATIVES NZ National Stage 769842 Issued
NCI E-213-2018-0-CA-05 TRITERPENE AMINE DERIVATIVES CA National Stage 3101643 Issued
NCI E-213-2018-0-ZA-03 TRITERPENE AMINE DERIVATIVES ZA National Stage 2020/07042 Issued
NCATS E-244-2014-0-US-09 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US DIV 16/455,848 10961200 Issued PDF
NCI E-213-2018-0-PCT-02 TRITERPENE AMINE DERIVATIVES PCT PCT PCT/US2019/039981 Expired
NCI E-213-2018-0-EP-07 TRITERPENE AMINE DERIVATIVES EP National Stage 19827166.0 Pending
NCI E-213-2018-0-AU-04 TRITERPENE AMINE DERIVATIVES AU National Stage 2019292599 Pending
NCI E-213-2018-0-IN-08 TRITERPENE AMINE DERIVATIVES IN National Stage 202037051582 Pending
NIAID E-066-2014-0-US-08 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US DIV 16/455,242 11147867 Issued PDF
NIBIB E-128-2018-2-PCT-01 SYSTEMS AND METHODS FOR IMPROVED AXIAL RESOLUTION IN MICROSCOPY USING PHOTOSWITCHING AND STANDING WAVE ILLUMINATION TECHNIQUES PCT PCT COMB PCT/US2019/039551 Expired
NIAID E-015-2017-0-US-06 METHODS FOR THE DETECTION OF TAU PROTEIN AGGREGATES US National Stage 16/474,040 11906530 Issued PDF
NCATS E-178-2018-0-US-02 Cell-based High-throughput High-content Assays Using Glycolytic Enzymes For Drug Discovery US ORD 16/452,767 Pending
NCI E-158-2018-0-PCT-02 ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS PCT PCT PCT/US2019/039239 Expired
NCI E-040-2012-0-CN-34 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen CN DIV 201910556436.1 Pending